Selected research
Industry Growth & Trends
Global Metformin Hydrochloride Preparation Industry Growth and Trends Forecast to 2032
Market perspective
The global Metformin Hydrochloride Preparation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metformin Hydrochloride Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metformin Hydrochloride Preparation include Yiling Pharmaceutical, Topfond Pharmaceutical, Teva Pharmaceuticals, CSPC, Sandoz, Sanofi, Nanjing Yewin, Merck and Jiangsu Deyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Metformin Hydrochloride Preparation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Metformin Hydrochloride Preparation market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metformin Hydrochloride Preparation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metformin Hydrochloride Preparation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Metformin Hydrochloride Preparation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Metformin Hydrochloride Preparation Market by Company
Yiling Pharmaceutical
Topfond Pharmaceutical
Teva Pharmaceuticals
CSPC
Sandoz
Sanofi
Nanjing Yewin
Merck
Jiangsu Deyuan Pharmaceutical
Sinocorp Pharma
Jingfeng Pharmaceutical Group
Bayer
Bristol Myers Squibb
Viatris
Sun Pharmaceutical Industries
Dr. Reddy's Laboratories
Apotex
Metformin Hydrochloride Preparation Segment by Type
Sustained Release Dosage
Regular Release Dosage
Metformin Hydrochloride Preparation Segment by Application
Hospital
Clinic
Other
Metformin Hydrochloride Preparation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metformin Hydrochloride Preparation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Metformin Hydrochloride Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sustained Release Dosage
- Regular Release Dosage
Applications
- Hospital
- Clinic
- Other
Companies covered
- Yiling Pharmaceutical
- Topfond Pharmaceutical
- Teva Pharmaceuticals
- CSPC
- Sandoz
- Sanofi
- Nanjing Yewin
- Merck
- Jiangsu Deyuan Pharmaceutical
- Sinocorp Pharma
- Jingfeng Pharmaceutical Group
- Bayer
- Bristol Myers Squibb
- Viatris
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metformin Hydrochloride Preparation Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metformin Hydrochloride Preparation Sales Estimates and Forecasts (2021-2032)
- 1.3 Metformin Hydrochloride Preparation Market by Type
- 1.3.1 Sustained Release Dosage
- 1.3.2 Regular Release Dosage
- 1.4 Global Metformin Hydrochloride Preparation Market Size by Type
- 1.4.1 Global Metformin Hydrochloride Preparation Market Size Overview by Type (2021-2032)
- 1.4.2 Global Metformin Hydrochloride Preparation Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Metformin Hydrochloride Preparation Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Metformin Hydrochloride Preparation Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Metformin Hydrochloride Preparation Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Metformin Hydrochloride Preparation Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Metformin Hydrochloride Preparation Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Metformin Hydrochloride Preparation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Metformin Hydrochloride Preparation Industry Trends
- 2.2 Metformin Hydrochloride Preparation Industry Drivers
- 2.3 Metformin Hydrochloride Preparation Industry Opportunities and Challenges
- 2.4 Metformin Hydrochloride Preparation Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Metformin Hydrochloride Preparation Revenue (2021-2026)
- 3.2 Global Top Players by Metformin Hydrochloride Preparation Sales (2021-2026)
- 3.3 Global Top Players by Metformin Hydrochloride Preparation Price (2021-2026)
- 3.4 Global Metformin Hydrochloride Preparation Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metformin Hydrochloride Preparation Major Company Production Sites & Headquarters
- 3.6 Global Metformin Hydrochloride Preparation Company, Product Type & Application
- 3.7 Global Metformin Hydrochloride Preparation Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metformin Hydrochloride Preparation Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metformin Hydrochloride Preparation Players Market Share by Revenue in 2025
- 3.8.3 2025 Metformin Hydrochloride Preparation Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride Preparation Regional Status and Outlook
- 4.1 Global Metformin Hydrochloride Preparation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Metformin Hydrochloride Preparation Historic Market Size by Region
- 4.2.1 Global Metformin Hydrochloride Preparation Sales in Volume by Region (2021-2026)
- 4.2.2 Global Metformin Hydrochloride Preparation Sales in Value by Region (2021-2026)
- 4.2.3 Global Metformin Hydrochloride Preparation Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Metformin Hydrochloride Preparation Forecasted Market Size by Region
- 4.3.1 Global Metformin Hydrochloride Preparation Sales in Volume by Region (2027-2032)
- 4.3.2 Global Metformin Hydrochloride Preparation Sales in Value by Region (2027-2032)
- 4.3.3 Global Metformin Hydrochloride Preparation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metformin Hydrochloride Preparation by Application
- 5.1 Metformin Hydrochloride Preparation Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Metformin Hydrochloride Preparation Market Size by Application
- 5.2.1 Global Metformin Hydrochloride Preparation Market Size Overview by Application (2021-2032)
- 5.2.2 Global Metformin Hydrochloride Preparation Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Metformin Hydrochloride Preparation Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Metformin Hydrochloride Preparation Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Metformin Hydrochloride Preparation Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Metformin Hydrochloride Preparation Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Metformin Hydrochloride Preparation Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Metformin Hydrochloride Preparation Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yiling Pharmaceutical
- 6.1.1 Yiling Pharmaceutical Company Information
- 6.1.2 Yiling Pharmaceutical Business Overview
- 6.1.3 Yiling Pharmaceutical Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yiling Pharmaceutical Metformin Hydrochloride Preparation Product Portfolio
- 6.1.5 Yiling Pharmaceutical Recent Developments
- 6.2 Topfond Pharmaceutical
- 6.2.1 Topfond Pharmaceutical Company Information
- 6.2.2 Topfond Pharmaceutical Business Overview
- 6.2.3 Topfond Pharmaceutical Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Topfond Pharmaceutical Metformin Hydrochloride Preparation Product Portfolio
- 6.2.5 Topfond Pharmaceutical Recent Developments
- 6.3 Teva Pharmaceuticals
- 6.3.1 Teva Pharmaceuticals Company Information
- 6.3.2 Teva Pharmaceuticals Business Overview
- 6.3.3 Teva Pharmaceuticals Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Teva Pharmaceuticals Metformin Hydrochloride Preparation Product Portfolio
- 6.3.5 Teva Pharmaceuticals Recent Developments
- 6.4 CSPC
- 6.4.1 CSPC Company Information
- 6.4.2 CSPC Business Overview
- 6.4.3 CSPC Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 CSPC Metformin Hydrochloride Preparation Product Portfolio
- 6.4.5 CSPC Recent Developments
- 6.5 Sandoz
- 6.5.1 Sandoz Company Information
- 6.5.2 Sandoz Business Overview
- 6.5.3 Sandoz Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sandoz Metformin Hydrochloride Preparation Product Portfolio
- 6.5.5 Sandoz Recent Developments
- 6.6 Sanofi
- 6.6.1 Sanofi Company Information
- 6.6.2 Sanofi Business Overview
- 6.6.3 Sanofi Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sanofi Metformin Hydrochloride Preparation Product Portfolio
- 6.6.5 Sanofi Recent Developments
- 6.7 Nanjing Yewin
- 6.7.1 Nanjing Yewin Company Information
- 6.7.2 Nanjing Yewin Business Overview
- 6.7.3 Nanjing Yewin Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Nanjing Yewin Metformin Hydrochloride Preparation Product Portfolio
- 6.7.5 Nanjing Yewin Recent Developments
- 6.8 Merck
- 6.8.1 Merck Company Information
- 6.8.2 Merck Business Overview
- 6.8.3 Merck Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Merck Metformin Hydrochloride Preparation Product Portfolio
- 6.8.5 Merck Recent Developments
- 6.9 Jiangsu Deyuan Pharmaceutical
- 6.9.1 Jiangsu Deyuan Pharmaceutical Company Information
- 6.9.2 Jiangsu Deyuan Pharmaceutical Business Overview
- 6.9.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Preparation Product Portfolio
- 6.9.5 Jiangsu Deyuan Pharmaceutical Recent Developments
- 6.10 Sinocorp Pharma
- 6.10.1 Sinocorp Pharma Company Information
- 6.10.2 Sinocorp Pharma Business Overview
- 6.10.3 Sinocorp Pharma Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Sinocorp Pharma Metformin Hydrochloride Preparation Product Portfolio
- 6.10.5 Sinocorp Pharma Recent Developments
- 6.11 Jingfeng Pharmaceutical Group
- 6.11.1 Jingfeng Pharmaceutical Group Company Information
- 6.11.2 Jingfeng Pharmaceutical Group Business Overview
- 6.11.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Preparation Product Portfolio
- 6.11.5 Jingfeng Pharmaceutical Group Recent Developments
- 6.12 Bayer
- 6.12.1 Bayer Company Information
- 6.12.2 Bayer Business Overview
- 6.12.3 Bayer Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Bayer Metformin Hydrochloride Preparation Product Portfolio
- 6.12.5 Bayer Recent Developments
- 6.13 Bristol Myers Squibb
- 6.13.1 Bristol Myers Squibb Company Information
- 6.13.2 Bristol Myers Squibb Business Overview
- 6.13.3 Bristol Myers Squibb Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Bristol Myers Squibb Metformin Hydrochloride Preparation Product Portfolio
- 6.13.5 Bristol Myers Squibb Recent Developments
- 6.14 Viatris
- 6.14.1 Viatris Company Information
- 6.14.2 Viatris Business Overview
- 6.14.3 Viatris Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Viatris Metformin Hydrochloride Preparation Product Portfolio
- 6.14.5 Viatris Recent Developments
- 6.15 Sun Pharmaceutical Industries
- 6.15.1 Sun Pharmaceutical Industries Company Information
- 6.15.2 Sun Pharmaceutical Industries Business Overview
- 6.15.3 Sun Pharmaceutical Industries Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Sun Pharmaceutical Industries Metformin Hydrochloride Preparation Product Portfolio
- 6.15.5 Sun Pharmaceutical Industries Recent Developments
- 6.16 Dr. Reddy's Laboratories
- 6.16.1 Dr. Reddy's Laboratories Company Information
- 6.16.2 Dr. Reddy's Laboratories Business Overview
- 6.16.3 Dr. Reddy's Laboratories Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Dr. Reddy's Laboratories Metformin Hydrochloride Preparation Product Portfolio
- 6.16.5 Dr. Reddy's Laboratories Recent Developments
- 6.17 Apotex
- 6.17.1 Apotex Company Information
- 6.17.2 Apotex Business Overview
- 6.17.3 Apotex Metformin Hydrochloride Preparation Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Apotex Metformin Hydrochloride Preparation Product Portfolio
- 6.17.5 Apotex Recent Developments
7 North America by Country
- 7.1 North America Metformin Hydrochloride Preparation Sales by Country
- 7.1.1 North America Metformin Hydrochloride Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Metformin Hydrochloride Preparation Sales by Country (2021-2026)
- 7.1.3 North America Metformin Hydrochloride Preparation Sales Forecast by Country (2027-2032)
- 7.2 North America Metformin Hydrochloride Preparation Market Size by Country
- 7.2.1 North America Metformin Hydrochloride Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Metformin Hydrochloride Preparation Market Size by Country (2021-2026)
- 7.2.3 North America Metformin Hydrochloride Preparation Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Metformin Hydrochloride Preparation Sales by Country
- 8.1.1 Europe Metformin Hydrochloride Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Metformin Hydrochloride Preparation Sales by Country (2021-2026)
- 8.1.3 Europe Metformin Hydrochloride Preparation Sales Forecast by Country (2027-2032)
- 8.2 Europe Metformin Hydrochloride Preparation Market Size by Country
- 8.2.1 Europe Metformin Hydrochloride Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Metformin Hydrochloride Preparation Market Size by Country (2021-2026)
- 8.2.3 Europe Metformin Hydrochloride Preparation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Metformin Hydrochloride Preparation Sales by Country
- 9.1.1 Asia-Pacific Metformin Hydrochloride Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Metformin Hydrochloride Preparation Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Metformin Hydrochloride Preparation Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Metformin Hydrochloride Preparation Market Size by Country
- 9.2.1 Asia-Pacific Metformin Hydrochloride Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Metformin Hydrochloride Preparation Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Metformin Hydrochloride Preparation Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Metformin Hydrochloride Preparation Sales by Country
- 10.1.1 South America Metformin Hydrochloride Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Metformin Hydrochloride Preparation Sales by Country (2021-2026)
- 10.1.3 South America Metformin Hydrochloride Preparation Sales Forecast by Country (2027-2032)
- 10.2 South America Metformin Hydrochloride Preparation Market Size by Country
- 10.2.1 South America Metformin Hydrochloride Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Metformin Hydrochloride Preparation Market Size by Country (2021-2026)
- 10.2.3 South America Metformin Hydrochloride Preparation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Metformin Hydrochloride Preparation Sales by Country
- 11.1.1 Middle East and Africa Metformin Hydrochloride Preparation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Metformin Hydrochloride Preparation Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Metformin Hydrochloride Preparation Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Metformin Hydrochloride Preparation Market Size by Country
- 11.2.1 Middle East and Africa Metformin Hydrochloride Preparation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Metformin Hydrochloride Preparation Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Metformin Hydrochloride Preparation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Metformin Hydrochloride Preparation Value Chain Analysis
- 12.1.1 Metformin Hydrochloride Preparation Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Metformin Hydrochloride Preparation Production Mode & Process
- 12.2 Metformin Hydrochloride Preparation Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Metformin Hydrochloride Preparation Distributors
- 12.2.3 Metformin Hydrochloride Preparation Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst